Investors sold shares of Danaher Corporation (NYSE:DHR) on strength during trading on Friday. $18.38 million flowed into the stock on the tick-up and $43.26 million flowed out of the stock on the tick-down, for a money net flow of $24.88 million out of the stock. Of all companies tracked, Danaher Corporation had the 0th highest net out-flow for the day. Danaher Corporation traded up $0.66 for the day and closed at $87.63

A number of research firms have commented on DHR. Wells Fargo & Company reaffirmed a “market perform” rating on shares of Danaher Corporation in a research report on Saturday, July 22nd. Cowen and Company reaffirmed a “buy” rating and issued a $90.00 target price on shares of Danaher Corporation in a research report on Wednesday. Jefferies Group LLC reaffirmed a “buy” rating and issued a $95.00 target price on shares of Danaher Corporation in a research report on Friday, August 4th. BidaskClub cut shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Tuesday, July 25th. Finally, Morgan Stanley reaffirmed an “overweight” rating and issued a $95.00 target price (up previously from $86.00) on shares of Danaher Corporation in a research report on Friday. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the stock. Danaher Corporation presently has a consensus rating of “Buy” and a consensus price target of $92.62.

The firm has a market cap of $60.88 billion, a price-to-earnings ratio of 27.97 and a beta of 1.03. The stock has a 50 day moving average of $85.07 and a 200 day moving average of $84.19.

Danaher Corporation (NYSE:DHR) last released its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.97 by $0.02. The business had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The company’s revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the company posted $0.90 EPS. Equities analysts expect that Danaher Corporation will post $3.95 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be paid a $0.14 dividend. This represents a $0.56 annualized dividend and a dividend yield of 0.64%. The ex-dividend date is Thursday, September 28th. Danaher Corporation’s dividend payout ratio is currently 17.83%.

In related news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the business’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $81.78, for a total transaction of $799,154.16. Following the transaction, the insider now directly owns 155,520 shares of the company’s stock, valued at approximately $12,718,425.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider William King sold 7,458 shares of the business’s stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $82.97, for a total value of $618,790.26. Following the transaction, the insider now directly owns 18,245 shares in the company, valued at $1,513,787.65. The disclosure for this sale can be found here. Insiders sold a total of 71,496 shares of company stock worth $5,916,223 over the last ninety days. Corporate insiders own 12.20% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in DHR. BlackRock Inc. lifted its position in Danaher Corporation by 2,530.9% during the 1st quarter. BlackRock Inc. now owns 37,967,922 shares of the conglomerate’s stock worth $3,247,398,000 after acquiring an additional 36,524,795 shares in the last quarter. Flossbach Von Storch AG lifted its position in Danaher Corporation by 44.7% during the 2nd quarter. Flossbach Von Storch AG now owns 5,782,019 shares of the conglomerate’s stock worth $487,945,000 after acquiring an additional 1,785,810 shares in the last quarter. Vanguard Group Inc. lifted its position in Danaher Corporation by 3.9% during the 1st quarter. Vanguard Group Inc. now owns 40,967,631 shares of the conglomerate’s stock worth $3,503,962,000 after acquiring an additional 1,530,015 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its position in Danaher Corporation by 16,410.0% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,485,901 shares of the conglomerate’s stock worth $125,395,000 after acquiring an additional 1,476,901 shares in the last quarter. Finally, Koch Industries Inc. lifted its position in Danaher Corporation by 29,127.3% during the 2nd quarter. Koch Industries Inc. now owns 1,404,665 shares of the conglomerate’s stock worth $1,388,000 after acquiring an additional 1,399,859 shares in the last quarter. 75.68% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: “Investors Sell Danaher Corporation (DHR) on Strength (DHR)” was first published by Watch List News and is the property of of Watch List News. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The correct version of this article can be read at https://www.watchlistnews.com/investors-sell-danaher-corporation-dhr-on-strength-dhr/1617471.html.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.